Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.24) earnings per share for the quarter, topping the consensus estimate of ($0.30) by $0.06, FiscalAI reports. Terns Pharmaceuticals Price Performance Shares of Terns Pharmaceuticals stock opened at $52.88 on Tuesday. The stock has a market cap of [...]
Terns Pharmaceuticals (NASDAQ:TERN) Issues Earnings Results, Beats Estimates By $0.06 EPS
